Cancer Care Costs High Among Privately Insured Patients
A recent analysis found that privately insured US patients with newly diagnosed cancer, especially those with more advanced disease, had 'substantial out-of-pocket costs.' Monthly out-of-pocket costs among these patients increased by a mean of almost $600, on average, but increased to nearly $720 per month for those with stage IV disease.
METHODOLOGY:
Out-of-pocket costs for cancer care in the US are rising, but most research has focused on Medicare beneficiaries. It's important to understand privately insured patients' financial burdens, especially with cancer rates growing among younger Americans.
Researchers conducted a retrospective study of 19,656 patients with cancer, using a dataset that links claims from a large private insurer to the Surveillance, Epidemiology, and End Results cancer registry.
Overall, 74.1% had breast cancer, 14.5% had colorectal cancer, and 11.4% had lung cancer. Analyses also included 26,502 individuals without cancer who were assigned pseudo – diagnosis date.
Monthly out-of-pocket costs (copays, co-insurance, and deductibles) were calculated from claims and inflation-adjusted to 2024 US dollars.
TAKEAWAY:
After a cancer diagnosis, monthly out-of-pocket costs rose by $592, on average.
Those added costs increased with disease stage, from $462 per month for stage 0 cancer to $720 per month for stage IV cancer.
Out-of-pocket costs spiked in the month of diagnosis and remained elevated for 6 months compared with those in individuals without cancer — totaling an average of $4145 in cumulative additional costs (over 7 months).
IN PRACTICE:
'In this cohort study, patients with private insurance were found to have high OOPCs [out-of-pocket costs] after an incident diagnosis of cancer, and those with the most advanced cancer had the highest OOPCs,' the authors wrote. 'The variability in OOPCs based on cancer stage underscores the need for policies such as paid sick leave, that address both insurance continuity and financial assistance, especially for patients with more advanced cancer.'
SOURCE:
This study, led by Liam Rose, PhD, Stanford University School of Medicine, Palo Alto, California, was published online in JAMA Network Open.
LIMITATIONS:
Differential insurance attrition could have affected the results: Patients with stage IV cancer were most likely to drop their coverage. The study could only capture direct medical costs, which misses other potential financial burdens, such as lost income and travel expenses.
DISCLOSURES:
This study received funding support through a grant from the American Cancer Society. One author reported receiving grants from the Department of Veterans Affairs and National Institutes of Health during the conduct of the study. No other disclosures were reported.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
First they took a GLP-1. Then they got the 'meat ick.'
It's hard to meet your protein goals when you suddenly can't stand a bite of chicken or steak. Merris Taylor has never loved a fatty ribeye or New York Strip steak. She prefers leaner cuts. But that preference morphed into a downright disgust after Taylor started taking Zepbound, a powerful GLP-1 weight loss medication. 'If I get a weird piece of meat in my mouth — whether it has a weird texture or fat in it — I'm like, 'oh, no,'' the dietitian tells Yahoo. 'That just turns your stomach,' she adds. This sudden loss of appetite for meat is not uncommon among people taking GLP-1s. They call it the 'meat ick.' If you're not on a weight loss medication, maybe you've felt a version of the meat ick if you've taken a first bite of salmon and it tasted too fishy, or you've cooked up some chicken that still tastes suspiciously gamey. But for some people taking injection weight loss drugs such as Zepbound and Wegovy, even the freshest chicken, pork, steak or salmon can lose its appeal. Researchers, patients and prescribers of GLP-1 medications are discovering that the drugs can significantly change people's tastes in food. And losing a taste for meat is especially concerning for people on these medications because they need to consume plenty of protein to prevent muscle loss and reduce side effects. So what's going on, and can a case of the meat ick be cured? Here's what we learned. What is the 'meat ick' and why do people get it on GLP-1s? The meat ick is just a more relatable version of a more technical term called food aversion. It's a phenomenon that's probably most familiar to people who have been pregnant and experienced the dreaded morning sickness along with appetite changes that can leave them hating their favorite foods. Food aversion can come with or without nausea and has a number of potential causes, ranging from hormonal changes, such as those in pregnancy, to certain illnesses and even mental health issues like depression or anxiety. Medications, including antibiotics and omeprazole — a common acid reflux treatment — can also cause food aversion. So the effects of blockbuster GLP-1 drugs aren't totally unprecedented. But something new is going on with these particular types of medications. Older diabetes medications that are also considered GLP-1s — including Victoza and Saxenda — have been around for more than a decade. 'What's very strange is that really nobody ever reported this meat ick thing to us [while taking these drugs],' Tiffany Bailey, a physician's assistant who makes educational content about GLP-1s on social media, tells Yahoo. 'What I found strange is that we started seeing this phenomenon when we started using GLP-1s for weight loss,' rather than to treat diabetes, she adds. There isn't much research on the meat ick or other food aversions triggered by GLP-1s — Bailey notes that it was never mentioned to her or her colleagues when they were learning how to prescribe and manage side effects — but there are some sensible theories. For one, Bailey suspects that the reason people are getting the meat ick while on, for example, Mounjaro, but not Saxenda, is that versions of drugs designed for weight loss are usually higher doses than the same medication formulated for diabetes treatment. That likely means the side effects of the weight loss versions will be stronger. Second, these drugs help people lose weight by slowing down gastric emptying, or the process of digestion. So after someone taking a GLP-1 eats, 'food just sits there longer,' helping them to feel fuller faster, explains Bailey. Heavy, dense foods, including meat and other proteins, already take longer to digest. But if they sit in your gut for too long, they can trigger nausea, a biological response designed to tell us Slow down, I've had enough and can't handle more right now! Your digestive system 'registers that you ate this, and it sat there and made you nauseous, so it will subconsciously tell your brain, 'This is bad.'' So your brain gets conditioned when it tastes, smells or in some cases even sees that food to think: nausea. It's not just meat Bailey estimates that between 10% and 15% of her GLP-1 patients with food aversions get the meat ick, specifically. But she says as many as 70% of people taking the injections develop some kind of food aversion. The most common culprit? Coffee, 'even if they used to live for their coffee,' says Bailey. Too much caffeine from coffee can cause nausea, queasiness or stomach upset, which might partially explain the phenomenon. But Bailey says that coffee simply tastes bad to many of her patients. Plenty of GLP-1 users have reported the same breakup with their morning joe on social media. One possible explanation is that both caffeine and GLP-1s interact with dopamine, our reward chemical, in the brain. GLP-1s can make those once-rewarding food and drinks (and, researchers think, drugs and alcohol too) less so, which may explain why coffee and caffeine aren't so appealing to those taking the drugs, Bailey suggests. Eggs are probably the second most commonly-reported 'ick' in Bailey's family medicine practice. And they're now 32-year-old Courtney Kline's biggest turn-off. Since starting to take a GLP-1, 'I've tried every which way to cook them or put them in something,' but to no avail, she tells Yahoo. 'I've always loved eggs, but the second I started on a GLP-1 I [tried to make] some eggs, liquid egg whites and spinach, and I felt like vomiting,' she says. Her egg reaction takes one easy way to cook and consume protein off the menu. But for others with the meat ick, including Taylor, eggs are a solution. While scrambled eggs are 'no-go' for her, boiled eggs are a great go-to source of protein, along with softer meats that are made in the crock pot, added to soup or in spaghetti sauce. Cassandra Smith has the opposite problem. A day or so after the 30-year-old middle school English teacher and mother took her first injection of compounded tirzepatide, Smith had plans to go to Olive Garden with her coworkers. Smith ordered her usual: cheese ravioli with red meat sauce, topped with a layer of Parmesan. 'When I got it, I was like, eww,' she tells Yahoo. 'I was like, 'I just can't eat this — this is disgusting.' The dish didn't smell off or look off, but 'it was like my brain just said, 'You're not eating that,' says Smith. 'It's weird, I can't really explain it.' Her best guess is simply that her brain and body have learned that all of that heavy food — the red meat, the carbs and the cheese — didn't sit well with her anymore. (Dairy, notes Bailey, also comes up as a GLP-1 ick.) Why the ick isn't all bad — and how to cope with it There's an upside to these icks, however. Smith no longer has any desire for some of the rich foods she once enjoyed. Instead, 'my cravings are completely different now. I crave salmon and brussels sprouts, and I'm wondering, 'What restaurant has the best broccoli?'' she says. 'I'm like, who craves broccoli? But my whole palate has changed.' That's been hugely helpful to Smith. She used to love steak, but had to stop eating it because it caused flare-ups of her rheumatoid arthritis. Since starting on a GLP-1 Smith has been able to stop taking her arthritis medications under the guidance of her doctor, 'and these are medications that people never come off of,' she says. Now she's discovered a love of salmon, a healthy, nutrient-packed source of protein and good-for-you fats. Smith avoids any highly processed 'manmade' foods, she says, opting instead for whole foods — and teaching her 4-year-old daughter to do the same. It's a common, positive effect of being on these weight loss medications, Bailey says. 'Studies show that people choose a lot lighter foods in general after being put on a GLP-1,' she says, referring to a shift away from high-sugar foods and unhealthy fats found in ultra-processed foods. That's good for weight loss and improving health metrics like cholesterol, blood pressure and blood sugar. But this dietary change does present a problem: consuming enough protein. Fatty fish like salmon and tuna are great sources of protein, but Bailey says some of her GLP-1 patients can't tolerate even this good fat. So how can you hit your protein goals if you're on a weight loss medication? Lean options like grilled chicken or turkey are less likely to trigger the ick, say both Bailey and Taylor. And, when in doubt, you might just have to hide the meat a little. Taylor and Bailey suggest going for lightly breaded chicken. Try cooking it in an air fryer or baking it in the oven, rather than deep-frying it, which bathes the chicken in fatty oil — or else you might find yourself right back in the ick. Solve the daily Crossword
New York Times
31 minutes ago
- New York Times
He Was Getting Weaker and More Confused. Could It Be His Drinking?
The woman struggled to get her 53-year-old husband out of the car and into the just-borrowed wheelchair. She rolled him through the crisp February air to the Emergency Department at Lawrence and Memorial Hospital in New London, Conn. They had driven straight from the neurosurgeon's office, where the physician assistant was shocked by how weak the man had become, how much worse he was than six weeks earlier when he last saw the patient. In the E.R., the man lay moaning quietly on the stretcher. His blood pressure was low, his heart rate was high. He could barely move his legs on his own, and when the E.R. doctor lifted each leg and let go, he couldn't hold them up. The doctors were worried something was compressing the man's spinal cord. The patient needed an M.R.I. right away. After the test, the man was given fluids. He hadn't been eating or drinking much for the past few weeks, his wife told the nurse. The M.R.I. showed wear and tear in his neck and some narrowing of the spinal column in his lower back, but it didn't seem enough to cause this profound weakness. Even so, the neurosurgeon who reviewed the results thought they should start him on intravenous steroids to bring down any swelling that might not have been seen on the M.R.I. That night, after his wife went home, the patient, tired and a little confused, could only provide the admitting doctor with a very basic story. His legs had started hurting a few months earlier. It began with a pins-and-needles feeling in his feet that over time moved upward. And he had terrible leg cramps. He couldn't sleep. He couldn't work. Then he couldn't walk. And now he was here. The doctor found the rest of the history in his chart. Back in September, his primary-care doctor sent him for an M.R.I. and tested him for B12 deficiency and, because this was Connecticut, for Lyme disease. His B12 was low, so she started him on a supplement. He didn't have Lyme disease. And that M.R.I. showed some osteoarthritis and mild compression, so she sent him to a neurosurgeon. He was given oral steroids and referred for physical therapy. Neither helped. By December, he was unable to leave the house. He fell several times. By January he was having problems with his memory. He missed appointments; didn't get ordered lab work. The patient had a long history of drinking, the doctor noted. The previous year, he was found guilty of driving under the influence and had to go to a court-ordered alcohol program. He was drinking less, he told the doctor. But still drinking. He had a drink earlier that day, he admitted. But only one. Want all of The Times? Subscribe.
CNN
31 minutes ago
- CNN
Covid-19 vaccine policy changes raise questions and concerns for US adults as summer wave ramps up
Vaccines Respiratory viruses Children's healthFacebookTweetLink Follow As Covid-19 transmission ramps up in the United States, recent changes to federal vaccine guidance have left many Americans confused about the latest policies and concerned about access to shots this fall. The US has had a summer surge in Covid-19 cases each year since the pandemic began. This year, however, experts say that the seasonal wave is starting later than anticipated and is relatively subdued. Surveillance data from WastewaterSCAN shows that median Covid-19 concentrations ticked up from June to July, with high levels in some parts of the country, but overall, it's far below this time last year. 'My hypothesis was that the weak winter wave would set the stage for a bigger summer, because many people would not have recent immunity. So far, activity has been more sedate than I anticipated,' epidemiologist Caitlin Rivers wrote in her newsletter Sunday. 'I remain open-minded about what August will bring. My best guess is continued increases until early September, but I am uncertain.' Although it's too early to know how big the current uptick will be or how long it will last, Dr. Jennifer Nuzzo, an epidemiologist and director of the Pandemic Center at the Brown University School of Public Health, says her key concern is whether Covid-19 vaccines will be available 'in time to protect people, especially those at high risk, against severe illness.' 'My biggest worry at this point is the uncertainty about when updated Covid vaccines will become available and who will be able to get them,' Nuzzo said. New survey data from KFF published Friday shows that most adults in the US don't plan to get a Covid-19 vaccine this fall, but most who do plan to get the shot share concerns that the vaccine won't be available to them and that their insurance won't cover the cost. In the past few months, US Department of Health and Human Services Secretary Robert F. Kennedy Jr. has said that the Covid-19 shot will no longer be recommended for healthy children and pregnant women, replaced a federal vaccine advisory panel and announced plans to examine the well-established federal childhood vaccine schedule. For the latest survey, KFF polled a nationally representative sample of nearly 1,300 adults between July 8 and 14 – at least two weeks after each of these events. About a quarter of US adults say Kennedy has made 'major' changes to vaccine policy in the US, but another 40% 'don't know enough to say,' the KFF poll found. Of those who do plan to get a Covid-19 vaccine this fall – more likely to be older adults and Democrats – about two-thirds say they are concerned that it might not be available to them. And more than 60% of insured adults who plan to get the shot are worried that their insurance won't cover it. About half of parents are not sure whether federal health agencies are currently recommending that healthy children receive a Covid-19 vaccine this fall, according to the new KFF data. Kennedy announced that the US Centers for Disease Control and Prevention will not formally recommend the Covid-19 vaccine for healthy children, leaving decisions to be made between parents and their health care provider. KFF found that personal doctors or health care providers remain the most trusted source for information about vaccines, with 8 in 10 adults saying they trust their own doctor at least 'a fair amount.' Trust in local health departments and the CDC has been eroding over the past two years, but most adults still say they trust these sources for vaccine information. But far fewer – only 37% of adults – say they trust Kennedy at least 'a fair amount' to provide information on vaccines, according to KFF. When asked about the impact of the changes to federal vaccine policy, more than a third of adults said they are making people less safe. Only 1 in 5 said the changes are making people safer. Rivers says she recommends that people who want their annual Covid-19 get it sooner rather than later. 'The big drawback is, it is not updated yet; the new formulation will be released closer to autumn,' she said, but getting a shot now will offer protection against the unpredictable summer wave and get ahead of access concerns that may arise in the future.
